Abstract
No public abstract is available from the verified source records.
Hongbo Zheng, Bojia Li, Tunan Ding, Peiyao Qin, Yidi Ma, Shunjingxiang Zhang, Zhangkai Li, Ruyang Li, Shuijie Li, Yin Fu
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease
10.15252/emmm.202216581 · 2023
Hypoxia-Inducible Factor 1-Alpha (HIF-1α): An Essential Regulator in Cellular Metabolic Control
2024
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024
Mitochondrial ROS, ER Stress, and Nrf2 Crosstalk in the Regulation of Mitochondrial Apoptosis Induced by Arsenite
10.3390/antiox11051034 · 2022
Mitochondria: It is all about energy
10.3389/fphys.2023.1114231 · 2023
The effect of unhealthy lifestyle on the pathogenesis of sick sinus syndrome: A life-guiding review
2024
Targeting mitochondria by lipid-selenium conjugate drug results in malate/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression
10.7150/ijbs.102424 · 2024
Potential Candidates of Natural Antioxidants From Herbs for Treating Lung Disorders: Focus on Redox Balance and Natural Products
10.1002/ptr.70008 · 2025
Integration of machine learning and experimental validation reveals new lipid-lowering drug candidates
10.1038/s41401-025-01539-1 · 2025
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
Citrullination modulation stabilizes HIF-1α to promote tumour progression
10.1038/s41467-024-51882-w · 2024
Circ_0000376 regulates miR-577/HK2/LDHA signaling pathway to promote the growth, invasion and glycolysis of osteosarcoma
10.1186/s13018-023-04520-y · 2024
Icariin against osteoporosis: a review of advances in molecular mechanisms to biomedical applications
10.3389/fphar.2025.1688847 · 2025
Icariin mediates autophagy and apoptosis of hepatocellular carcinoma cells induced by the β-catenin signaling pathway through lncRNA LOXL1-AS1
10.1007/s00210-024-03692-6 · 2025
Cancer cachexia: biomarkers and the influence of age
2024
Icariin promoted ferroptosis by activating mitochondrial dysfunction to inhibit colorectal cancer and synergistically enhanced the efficacy of PD-1 inhibitors
10.1016/j.phymed.2024.156224 · 2025
Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype
10.1038/s41467-023-40745-5 · 2023
Metabolic reprogramming in lung cancer and its clinical implication
10.3389/fphar.2024.1516650 · 2024
GDF15: from biomarker to target in cancer cachexia
10.1016/j.trecan.2025.06.007 · 2025
Modern therapies of nonsmall cell lung cancer
10.1007/s13353-023-00786-4 · 2023
Inhibition of TFAM-Mediated Mitophagy by Oroxylin A Restored Sorafenib Sensitivity Under Hypoxia Conditions in HepG2 Cells
10.3390/ph17121727 · 2024
Icariin Inhibits Lung Adenocarcinoma Progression Through TP53-Mediated Ferroptosis
10.2147/ott.s539483 · 2025
A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds
10.1016/j.redox.2017.09.020 · 2018
Skeletal muscle endothelial dysfunction through the activin A–PGC1α axis drives progression of cancer cachexia
10.1038/s43018-025-00975-6 · 2025
Current status and trend of mitochondrial research in lung cancer: A bibliometric and visualization analysis
10.1016/j.heliyon.2024.e34442 · 2024
Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death
10.1080/15548627.2020.1739447 · 2021
Autophagy and Glycometabolic Reprograming in the Malignant Progression of Lung Cancer: A Review
10.1177/15330338231190545 · 2023
Icariin as a potential anticancer agent: a review of its biological effects on various cancers
2023
TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic mitochondrial DNA
10.1038/s41556-024-01419-6 · 2024
Icariin as an emerging candidate drug for anticancer treatment: Current status and perspective
10.1016/j.biopha.2022.113991 · 2023
Epithelial–Mesenchymal Transition in Osteosarcoma as a Key Driver of Pulmonary Metastasis
10.3390/cancers17172922 · 2025
Rewiring cancer metabolism: oncogenic signaling pathways and targeted therapeutics
10.1007/s11427-025-2979-3 · 2025
Roles of LonP1 in Oral-Maxillofacial Developmental Defects and Tumors: A Novel Insight
10.3390/ijms232113370 · 2022
Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicing
10.1186/s13046-023-02723-z · 2023
Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality
10.3389/fphar.2024.1422686 · 2024
Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction
10.1007/s10456-024-09938-4 · 2024
Metabolic adaptation in hypoxia and cancer
10.1016/j.canlet.2020.12.020 · 2021
Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
10.3390/ijms25020807 · 2024
Ginsenoside Rb1 attenuates coronary microvascular inflammatory injury via NDUFS4-SIRT5-DUSP1-mediated mitochondrial quality control in a murine ischemia-reperfusion model
10.1016/j.jgr.2025.04.006 · 2025
Tanshinone IIA modulates Sirt5 and Metll3 interaction to govern mitochondria-endoplasmic reticulum unfolded protein response in coronary microvascular injury
10.1016/j.phymed.2025.156982 · 2025
The regulatory roles and clinical significance of glycolysis in tumor
10.1002/cac2.12549 · 2024
Mitochondrial dysfunction: mechanisms and advances in therapy
10.1038/s41392-024-01839-8 · doi-reference
Icariin inhibits the malignant progression of lung cancer by affecting the PI3K/Akt pathway through the miR‑205‑5p/PTEN axis
10.3892/or.2022.8326 · doi-reference
TRMT10C-mediated m7G modification of circFAM126A inhibits lung cancer growth by regulating cellular glycolysis
10.1007/s10565-024-09918-w · doi-reference
A TCM Formula YYWY Inhibits Tumor Growth in Non-Small Cell Lung Cancer and Enhances Immune-Response Through Facilitating the Maturation of Dendritic Cells
10.3389/fphar.2020.00798 · doi-reference
Astragaloside VI attenuates mechanical stress-induced cardiac remodeling through piezo1-VDAC1 dependent endoplasmic reticulum unfolded protein response
10.1016/j.phymed.2025.157288 · doi-reference
Ginsenoside compound K-based multifunctional liposomes for the treatment of rheumatoid arthritis
10.1080/10717544.2025.2464190 · doi-reference
Understanding Immunomodulation and Managing Cancer Cachexia: A Narrative Review
10.2174/012212697x400236250630115449 · doi-reference
Mitochondrial quality control proteases and their modulation for cancer therapy
10.1002/med.21929 · doi-reference
LONP1 alleviates ageing-related renal fibrosis by maintaining mitochondrial homeostasis
10.1111/jcmm.70090 · doi-reference
CAF-derived exosomal LncRNA ANRIL promotes glycolytic metabolism and proliferation in non-small cell lung cancer via the miR-186-5p/HIF-1α axis
10.1007/s12672-025-03109-7 · doi-reference
Silencing ZIC5 suppresses glycolysis and promotes disulfidptosis in lung adenocarcinoma cells
10.1080/15384047.2025.2501780 · doi-reference
Differential Expression of Lonp1 Isoforms in Cancer Cells
10.3390/cells11233940 · doi-reference
Current Research on the Application of Xuefu Zhuyu Decoction and Its Modifications in the Treatment of Lung Cancer
10.53469/jcmp.2024.06(12).40 · doi-reference
Correlation between TCM Constitutional Types and Lung Carcinoma in Various Geographical Areas: A Systematic Review and Meta-Analysis
10.1155/2022/5660231 · doi-reference
Long Non-Coding RNA DUXAP8 Facilitates Cell Viability, Migration, and Glycolysis in Non-Small-Cell Lung Cancer via Regulating HK2 and LDHA by Inhibition of miR-409-3p
10.2147/ott.s243542 · doi-reference
The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance
10.2174/0118761429266116231123160809 · doi-reference
Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation
10.1038/s41467-024-55768-9 · doi-reference
Potential of natural drug modulation of endoplasmic reticulum stress in the treatment of myocardial injury
10.1016/j.jpha.2024.101034 · doi-reference
Targeting glycolysis in non-small cell lung cancer: Promises and challenges
10.3389/fphar.2022.1037341 · doi-reference
Traditional Chinese medicine in lung cancer treatment
10.1186/s12943-025-02245-6 · doi-reference
Microtubules and cardiovascular diseases: insights into pathology and therapeutic strategies
10.1016/j.biocel.2024.106650 · doi-reference
Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance
10.1186/s12951-025-03420-z · doi-reference
Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy
10.7150/ijbs.95853 · doi-reference
Mitochondrial Dysfunction Associated with mtDNA in Metabolic Syndrome and Obesity
10.3390/ijms241512012 · doi-reference
HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications
10.1016/j.lfs.2024.122890 · doi-reference
Mitochondrial DNA mutations in ageing and cancer
10.1002/1878-0261.13291 · doi-reference
Advances of HIF-1α/glycolysis axis in non-small cell lung cancer (Review)
10.3892/or.2024.8714 · doi-reference
A novel ligustrazine-based nanodelivery system protects against doxorubicin-induced cardiotoxicity by targeting the SIRT5-DUSP1 axis for mitochondrial repair
10.1186/s12951-025-03667-6 · doi-reference
Powering down the mitochondrial LonP1 protease: a novel strategy for anticancer therapeutics
10.1080/14728222.2023.2298358 · doi-reference
Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics
10.1016/j.semcancer.2022.11.007 · doi-reference
Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer
10.1038/s41467-022-32135-0 · doi-reference